Currently, Jupiter Neurosciences Inc’s (JUNS) stock is trading at $2.15, marking a gain of 12.57% from last night’s close. At this price, the stock is -88.98% below its 52-week high of $19.51 and 321.57% above its 52-week low of $0.51. Based on the past 30-day period, the stock price is -5.68% below the high and +138.94% above the low.
JUNS’s price to book ratio for the most recent quarter was 23.22, resulting in an 26.26 price to cash per share for the period.
How does Jupiter Neurosciences Inc (JUNS) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Jupiter Neurosciences Inc (NASDAQ: JUNS) Ownership Details
I will give a breakdown of the key shareholders in Jupiter Neurosciences Inc (JUNS). Recent figures show that the company’s insiders hold 54.18% of shares. A total of 7 institutional investors hold shares in the company, making 1.17% of its stock and 2.56% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is UBS Group AG holding total of 135.64 shares that make 0.41% of the company’s total number of shares and are currently priced at 0.3 million.
The securities firm Citigroup Inc. holds 111.98 shares of JUNS, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.34% , and the holding percentage of shares is valued at 0.25 million.
An overview of Jupiter Neurosciences Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Jupiter Neurosciences Inc (JUNS) traded 670,065 shares per day, with a moving average of $1.2768 and price change of +0.1605. With the moving average of $0.9497 and a price change of +1.5129, about 508,268 shares changed hands on average over the past 50 days. Finally, JUNS’s 100-day average volume is 319,147 shares, alongside a moving average of $0.8057 and a price change of +1.3198.
